Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DOXERCALCIFEROL USP, with a corresponding US DMF Number 25594.
Remarkably, this DMF maintains an Active status since its submission on January 19, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 01, 2015, and payment made on May 22, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II